Aloetherapeutics
2 known investors
Aloe Therapeutics develops AIM-001, a localized cell-based immunotherapy implanted at tumor sites during surgery to activate the immune system and improve response to checkpoint immunotherapy in patients with advanced solid tumors.
BiotechMedical Devices
Investors · 2
Frequently asked questions
- What does Aloetherapeutics do?
- Aloe Therapeutics develops AIM-001, a localized cell-based immunotherapy implanted at tumor sites during surgery to activate the immune system and improve response to checkpoint immunotherapy in patients with advanced solid tumors.
- Who are Aloetherapeutics's investors?
- Aloetherapeutics's investors include Maryland TEDCO, TEDCO.